PATENT CLAIM ANALYSIS

Application Number: 15775986
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "453000"]

Abstract:
Disclosed are bruceolides for the treatment of cancer, and other diseases, selectively targeting unwanted cells. The disclosed bruceolides may include a site specific cleavable moiety inhibiting the chemotoxic activity until cleaved, i.e., removed, within and/or near a cancer to be treated. As to facilitate selective delivery to cancer tumors, the disclosed bruceolides may be loaded into, attached to or otherwise carried by nanoparticles.

Claim (Index 30):
The method of  claim 29  wherein the composition further comprises nanoparticles, the nanoparticles having at least one of the compound of Formula (1) attached thereto, the compound Formula (1) attached nanoparticles having attached bruceolides according Formula (1), having bruceolides according to Formula (1) loaded therein and/or otherwise carrying bruceolides according to Formula (1).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.40385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15652947', '12573591', '14434300', '13891341', '12744982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7290335623754068
- 35 USC 102 Novelty (BERT): 0.5069950719699599
- Combined Prediction Score: 0.7068297133348622
- Mean Citation Score: 234.968964
- Max Citation Score: 241.52362
- Similarity Product: 158.1124523682785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test